OA03.05 Analysis of Early Survival in Patients with Advanced Non-Squamous NSCLC Treated with Nivolumab vs Docetaxel in CheckMate 057

Authors :: Frederico Cappuzzo
Julie R. Brahmer
Haolan Lu
Diane Healey
David R. Spigel
Solange Peters
Enriqueta Felip
Martin Steins
Brian Lestini
Cecile Dorange
Prabhu Bhagavatheeswaran
Teresa Sanchez
Hossein Borghaei
Luis Paz-Ares
Leora Horn
Fabrice Barlesi
James Novotny
Source :: Journal of Thoracic Oncology. 12:S253
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: 0301 basic medicine
Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
business.industry
Checkmate
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Docetaxel
Non squamous
030220 oncology & carcinogenesis
Internal medicine
medicine
In patient
Nivolumab
business
medicine.drug

Tools